DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
Current Location:
> This Story

Forward Printable StoryPrint Comment




Molecular Imaging Homepage

Eden Radioisotopes secures reactor project funding for medical isotope production

MILabs selected by Columbia University Irving Medical Center for upgrades to its molecular imaging capabilities

Blue Earth Diagnostics continues to expand access to Axumin (fluciclovine (18F)) in Europe

NRC calls for additional feedback on training and experience requirements for radiopharmaceuticals requiring a written directive

SHINE breaks ground on medical isotope production facility

MR Solutions' PET/MRI scanner explores innovative magnetic nanoparticles as a bimodal imaging agent

ITM builds new production site in Munich area

NorthStar Medical closes $100 million financing with Oberland Capital to expand domestic Mo-99 radioisotope production capacity

Zionexa completes a second $5 million capital raise

SNMMI and ACR collaborate on clinical data registry for nuclear medicine

MILabs installs new E-Class SPECT/CT system to enhance heart failure research at CHFC in Germany

Press releases may be edited for formatting or style
Würzburg, Germany and Utrecht, the Netherlands -- The nuclear cardiology core facility of the CHFC-Würzburg has acquired MILabs E-class SPECT/CT system to enhance its existing top-level basic, translational and clinical research activities in the field of heart failure. Upgradeable with simultaneous PET imaging, the E-Class SPECT/CT system combines economic use with exceptional translational imaging performance. The system features list mode based simultaneous high-resolution multi-isotope gated cardiac imaging capabilities - a critical performance feature for gaining better insights into, e.g. cardiac neuronal and vascular biology.

With an estimated 3 million heart failure patients in Germany and over 30 million worldwide, the CHFC- Würzburg uses world-class multi-disciplinary research for the development of new therapeutic strategies, which intervene early in the healing and remodeling processes of the heart.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

Prof. Dr. Takahiro Higuchi, Head of Pre-Clinical Imaging comments:” The use of high-end SPECT imaging fused with the anatomical structure of the heart obtained with low-dose CT is essential for translational cardiology imaging. For instance, one can uniquely visualize cardiac sympathetic nervous activity with this high-resolution nuclear imaging technique.

According to Prof. F. Beekman, founder & CEO of MILabs B.V.:” We are delighted to collaborate with Dr. T. Higuchi’s team to optimize the performance of our multimodality E-Class imaging system for cardiac applications. Because of the high spatial and temporal resolution of our nuclear imaging technologies, the system allows both global as well as regional functional and dynamic kinetic analysis. Once upgraded with PET, by eliminating positron range blurring, the system enables, for the first time, murine cardiac imaging with 82Rb, a popular PET tracer used in the clinic.”

About the Comprehensive Heart Failure Center (CHFC):
The CHFC is the heart research center of the Medical Faculty of the University of Würzburg. The CHFC in one out of eight German integrated research and treatment centers. It is the only center focused on heart failure disease, and the institute uses a comprehensive, multidisciplinary approach to research and treat illness. Within its large 5500 m2 new building on the campus of the University Clinic Wuerzburg, the center has four “Core facilities” - imaging, genetics, translational research, and clinical research & epidemiology, which provide modern and high-performance equipment and specialized personal expertise to both internal and external research groups. For more information, visit:

About MILabs B.V.
The company has a history of providing a continuum of innovations to expand the applications of its multimodality imaging solutions used for the development of new diagnostic solutions and therapies. With its latest adaptive preclinical platform, MILabs has succeeded at commercializing a scalable imaging platform, able to accommodate PET, SPECT, Optical and CT imaging in a single integrated and user-friendly system. Awarded the Commercial Innovation of the Year 2018 at the Molecular Imaging Congress, this platform is globally recognized for being able to deliver the highest quality molecular, functional and anatomical images. For more information, visit: or contact MILabs at

Molecular Imaging Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2019, Inc.